학술논문

Pre-clinical assessment of combined ABT-263/Navitoclax and ABT-414 or ABBV-321 treatment for EGFR-expressing TNBC
Document Type
Journal
Source
CANCER RESEARCH; FEB 2020, 80 4, 2p. Supplement: S
Subject
Language
English
ISSN
15387445